Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
CASI
#3957
CASI Pharmaceuticals, Inc. Ordinary Shares
0.2
1
-73.75%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-73.75%
Variazione Mensile
-78.79%
Variazione di 6 mesi
-90.41%
Variazione Annuale
-91.36%
Chiusura Precedente
0.8
0
Open
0.2
1
Bid
Ask
Low
0.2
1
High
0.2
1
Volume
17
Mercati
Mercato Azionario Statunitense
Salute
CASI
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2022
2023
2024
TTM
Key stats
Total common shares outstanding
13.46 M
13.38 M
15.49 M
—
Valuation ratios
Enterprise value
—
79.49 M
30.34 M
—
Price to earnings ratio
—
-3.57
-1.11
—
Price to sales ratio
—
2.85
1.52
—
Price to cash flow ratio
—
-4.83
-1.49
—
Price to book ratio
—
3.99
23.45
—
Enterprise value to EBITDA ratio
—
-24.24
-0.78
—
Profitability ratios
Return on assets %
0.43
0.36
0.73
—
Return on equity %
0.92
1.12
21.21
—
Return on invested capital %
337.4
264.42
384.92
—
Gross margin %
63.28
59.19
39.06
—
Operating margin %
78.95
74.03
138.84
—
EBITDA margin %
-76.95
-9.68
-137.34
—
Net margin %
95.14
79.58
137.57
—
Liquidity ratios
Quick ratio
3.96
2.6
0.94
—
Current ratio
4.32
3.55
1.09
—
Inventory turnover
2.58
1.25
1.64
—
Asset turnover
0.45
0.4
0.44
—
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
—
0.25
0.35
—
Long term debt to total equity ratio
—
0.78
10.21
—
Per share metrics
Operating cash flow per share
1.55
1.49
1.9
—
EBIT per share
-2.52
-0.43
-2.64
—
EBITDA per share
-2.43
-0.25
-2.55
—
Total debt per share
—
—
—
—
Cash per share
3.65
2.18
0.99
—
Net current asset value per share
5.38
4.44
2.58
—
Tangible book value per share
3.19
1.67
0.11
—
Working capital per share
4.13
3.19
0.2
—
Book value per share
3.27
1.81
0.12
—
Notizie
What Drove CASI Pharmaceuticals' 24% Rise After Hours? - CASI Pharmaceuticals (NASDAQ:CASI)
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%
Il titolo CASI Pharmaceuticals crolla dopo la notifica di delisting dal Nasdaq
CASI Pharmaceuticals stock plunges on Nasdaq delisting notice
Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year?
Are Medical Stocks Lagging Alkermes (ALKS) This Year?
China approves CASI Pharmaceuticals’ CID-103 clinical trial for kidney rejection
Il titolo CASI Pharmaceuticals balza dopo la proroga del Nasdaq
CASI Pharmaceuticals ottiene proroga per la quotazione al Nasdaq fino a febbraio 2026
CASI Pharmaceuticals stock surges after Nasdaq grants listing extension
Casi Pharmaceuticals secures Nasdaq listing extension until February 2026
CASI Pharmaceuticals secures $20 million funding for transplant rejection study